BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37958627)

  • 1. Global Proteomics for Identifying the Alteration Pathway of Niemann-Pick Disease Type C Using Hepatic Cell Models.
    Miyoshi K; Hishinuma E; Matsukawa N; Shirasago Y; Watanabe M; Sato T; Sato Y; Kumondai M; Kikuchi M; Koshiba S; Fukasawa M; Maekawa M; Mano N
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Analysis of Niemann-Pick Type C Hepatocytes Reveals Potential Therapeutic Targets for Liver Damage.
    Balboa E; Marín T; Oyarzún JE; Contreras PS; Hardt R; van den Bosch T; Alvarez AR; Rebolledo-Jaramillo B; Klein AD; Winter D; Zanlungo S
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard-flow LC and thermal focusing ESI elucidates altered liver proteins in late stage Niemann-Pick, type C1 disease.
    Pergande MR; Zarate E; Haney-Ball C; Davidson CD; Scesa G; Givogri MI; Bongarzone ER; Cologna SM
    Bioanalysis; 2019 Jun; 11(11):1067-1083. PubMed ID: 31251104
    [No Abstract]   [Full Text] [Related]  

  • 4. Loss of amyloid precursor protein exacerbates early inflammation in Niemann-Pick disease type C.
    Shin SD; Shin A; Mayagoitia K; Siebold L; Rubini M; Wilson CG; Bellinger DL; Soriano S
    J Neuroinflammation; 2019 Dec; 16(1):269. PubMed ID: 31847862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative, Label-Free Proteomics in the Symptomatic Niemann-Pick, Type C1 Mouse Model Using Standard Flow Liquid Chromatography and Thermal Focusing Electrospray Ionization.
    Pergande MR; Nguyen TTA; Haney-Ball C; Davidson CD; Cologna SM
    Proteomics; 2019 May; 19(9):e1800432. PubMed ID: 30888112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β metabolism in Niemann-Pick C disease models and patients.
    Mattsson N; Olsson M; Gustavsson MK; Kosicek M; Malnar M; Månsson JE; Blomqvist M; Gobom J; Andreasson U; Brinkmalm G; Vite C; Hecimovic S; Hastings C; Blennow K; Zetterberg H; Portelius E
    Metab Brain Dis; 2012 Dec; 27(4):573-85. PubMed ID: 22935999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.
    Subramanian K; Rauniyar N; Lavalleé-Adam M; Yates JR; Balch WE
    Mol Cell Proteomics; 2017 Nov; 16(11):1938-1957. PubMed ID: 28860124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Alteration Analysis of Steroid Hormones in Niemann-Pick Disease Type C Model Cell Using Liquid Chromatography/Tandem Mass Spectrometry.
    Abe A; Maekawa M; Sato T; Sato Y; Kumondai M; Takahashi H; Kikuchi M; Higaki K; Ogura J; Mano N
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann-Pick Type C Using Quantitative Proteomics.
    Cougnoux A; Pergande MR; Serna-Perez F; Cologna SM
    J Am Soc Mass Spectrom; 2023 Apr; 34(4):668-675. PubMed ID: 36920149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.
    Rauniyar N; Subramanian K; Lavallée-Adam M; Martínez-Bartolomé S; Balch WE; Yates JR
    Mol Cell Proteomics; 2015 Jul; 14(7):1734-49. PubMed ID: 25873482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Niemann-Pick type C disease and psychosis: Two siblings].
    Maubert A; Hanon C; Metton JP
    Encephale; 2015 Jun; 41(3):238-43. PubMed ID: 25238906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.
    Cologna SM; Jiang XS; Backlund PS; Cluzeau CV; Dail MK; Yanjanin NM; Siebel S; Toth CL; Jun HS; Wassif CA; Yergey AL; Porter FD
    PLoS One; 2012; 7(10):e47845. PubMed ID: 23144710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1.
    Singhal A; Szente L; Hildreth JEK; Song B
    Cell Death Dis; 2018 Oct; 9(10):1019. PubMed ID: 30282967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Proteomics Reveals miR-155 as a Novel Indicator of Liver and Spleen Pathology in the Symptomatic Niemann-Pick Disease, Type C1 Mouse Model.
    Pergande MR; Cougnoux A; Rathnayake RAC; Porter FD; Cologna SM
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30870990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
    Maubert A; Hanon C; Metton JP
    Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPC1-mTORC1 Signaling Couples Cholesterol Sensing to Organelle Homeostasis and Is a Targetable Pathway in Niemann-Pick Type C.
    Davis OB; Shin HR; Lim CY; Wu EY; Kukurugya M; Maher CF; Perera RM; Ordonez MP; Zoncu R
    Dev Cell; 2021 Feb; 56(3):260-276.e7. PubMed ID: 33308480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.
    Dominko K; Rastija A; Sobocanec S; Vidatic L; Meglaj S; Lovincic Babic A; Hutter-Paier B; Colombo AV; Lichtenthaler SF; Tahirovic S; Hecimovic S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease.
    Alvarez AR; Klein A; Castro J; Cancino GI; Amigo J; Mosqueira M; Vargas LM; Yévenes LF; Bronfman FC; Zanlungo S
    FASEB J; 2008 Oct; 22(10):3617-27. PubMed ID: 18591368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-symptomatic activation of antioxidant responses and alterations in glucose and pyruvate metabolism in Niemann-Pick Type C1-deficient murine brain.
    Kennedy BE; LeBlanc VG; Mailman TM; Fice D; Burton I; Karakach TK; Karten B
    PLoS One; 2013; 8(12):e82685. PubMed ID: 24367541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker analysis of Niemann-Pick disease type C using chromatography and mass spectrometry.
    Maekawa M; Iwahori A; Mano N
    J Pharm Biomed Anal; 2020 Nov; 191():113622. PubMed ID: 32998104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.